Return to search results
Uridine triacetate
XURIDEN is a prescription drug containing uridine triacetate, available as oral granules (2g per packet). Manufactured by BTG International Inc, it's a pyrimidine analog used in medical emergencies, such as treating toxicity from certain chemotherapy drugs. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | XURIDEN is a prescription drug containing uridine triacetate, available as oral granules (2g per packet). Manufactured by BTG International Inc, it's a pyrimidine analog used in medical emergencies, such as treating toxicity from certain chemotherapy drugs. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Uridine triacetate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Uridine triacetate — ANDA 208159 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208159"
}
]
|
| identifier | ANDA208159 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Uridine triacetate |
